ModelEdge

Oyster Point Pharma Inc.
0001720725
Filing Type8-K
Filing Date1/2/2023
Updated1/3/23, 2:12 AM

Filing

8-K
Earnings Release

Exhibits

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EX-3.1
EX-3.2EX-3.2